Premium CJC-1295 No DAC + Ipamorelin Blend for Sale | 10mg per Vial | ≥99% Purity | 48-Hour Delivery Across EU & UK

CJC-1295 (No DAC) + Ipamorelin Blend: The Synergistic Peptide Combination for Advanced Growth Hormone Research

eupeptidelap.co.uk is proud to present the CJC-1295 (No DAC) + Ipamorelin 10mg Blend, a premium research-grade peptide combination that represents a foundational tool for investigators exploring the growth hormone (GH) axis, tissue regeneration, and metabolic function. As a trusted peptide vendor uk and leading EU peptide supplier, we provide researchers across Europe with this synergistic blend for sale that delivers exceptional purity, consistency, and documented quality .

This dual-peptide research blend combines CJC-1295 (No DAC) , a synthetic analog of growth hormone-releasing hormone (GHRH), with Ipamorelin, a highly selective growth hormone secretagogue receptor (GHSR) agonist . Each vial contains 10mg of the precisely blended formulation, supplied as a lyophilized solid to maintain long-term stability and integrity. HPLC-verified at ≥99% purity with full Certificates of Analysis provided, this blend is widely studied in laboratory models of growth hormone dynamics, metabolic regulation, and tissue repair .

CJC-1295 is a synthetic peptide designed to mimic the action of endogenous GHRH. It stimulates the pituitary gland to increase the secretion of growth hormone (GH) and subsequently insulin-like growth factor 1 (IGF-1) . The “No DAC” (Drug Affinity Complex) variant indicates that this version does not contain the acetate that binds to albumin, resulting in a shorter half-life that mimics the body’s natural pulsatile GH release rather than a constant “bleed” . This makes the No DAC version preferable for research aimed at preserving physiological pulsatility .

Ipamorelin is a pentapeptide classified as a growth hormone secretagogue. It functions as a ghrelin receptor agonist, binding to GHSR-1a receptors on the pituitary gland to stimulate GH release . What distinguishes Ipamorelin from other GHRPs is its remarkable selectivity—it stimulates GH release without significantly influencing prolactin, cortisol, or adrenocorticotropic hormone (ACTH) levels . This selectivity profile makes it an invaluable tool for endocrine research where minimizing confounding variables is essential .

For researchers seeking to buy peptide online EU for investigations into growth hormone dynamics, muscle recovery, metabolic health, or anti-aging mechanisms, eupeptidelap.co.uk offers this premium research blend with comprehensive documentation, including Certificates of Analysis and batch-specific purity data. Whether your laboratory is based in London, Berlin, Paris, or anywhere in the European Union, our guaranteed 48 hour delivery peptide service ensures your research continues without interruption.

The Scientific Foundation of CJC-1295 + Ipamorelin Research

Understanding the Synergistic Mechanism

The CJC-1295 and Ipamorelin blend represents a strategic combination of two peptides that target distinct receptors within the growth hormone axis, offering synergistic effects that surpass what either peptide might achieve alone .

CJC-1295 (No DAC): GHRH Receptor Activation

CJC-1295 is a synthetic analog of growth hormone-releasing hormone (GHRH) that binds to GHRH receptors on somatotroph cells in the anterior pituitary gland . This binding activates G-proteins, leading to the production of cyclic adenosine monophosphate (cAMP) as a secondary messenger. Elevated cAMP levels activate protein kinases that influence gene expression for increased growth hormone synthesis .

The “No DAC” formulation is particularly significant for research focused on physiological pulsatility. The absence of the Drug Affinity Complex means the peptide has a shorter half-life, creating a more natural, pulsatile GH release pattern rather than a continuous elevation . This is important for studies where maintaining the body’s natural hormonal rhythms is a consideration.

Ipamorelin: GHSR Receptor Activation

Ipamorelin is a selective growth hormone secretagogue receptor (GHS-R) ligand, also referred to as the ghrelin receptor . Upon binding to GHS-Rs, Ipamorelin engages distinct signaling pathways:

PLC Activation: Ipamorelin binding activates phospholipase C (PLC), which catalyzes the production of secondary messengers that increase intracellular calcium and activate protein kinase C (PKC), culminating in GH-containing vesicle exocytosis .
Somatostatin Suppression: Studies suggest that GHSR agonists like Ipamorelin also cause significant GH release by suppressing somatostatin (an antagonist to GHRH), in addition to stimulating GH release from the anterior pituitary .
Selective Action: Unlike other GHRPs, Ipamorelin has no effect on the release of adrenocorticotropic hormone, prolactin, follicle-stimulating hormone, luteinizing hormone, thyroid-stimulating hormone, or cortisol . This high selectivity makes it particularly valuable for isolating GH-specific effects in research.

Synergistic Potential

The differences in how each peptide interacts with pituitary cells have led researchers to hypothesize that using both compounds simultaneously may yield synergistic actions on growth hormone secretion . CJC-1295 provides a sustained signal to the pituitary to release GH, while Ipamorelin shapes the timing and smoothness of each pulse . This synchrony mirrors the body’s preferred growth hormone pattern, avoiding harsh spikes and creating a smoother rise and fall .

The combination is often described as a “foundational stack” for restoring hormonal rhythm, sleep quality, energy, and physiologic GH pulsatility . It targets both upstream pituitary stimulation and downstream tissue response for comprehensive GH optimization .

Key Research Applications

Growth Hormone Signaling and Pituitary Research

The CJC-1295 and Ipamorelin blend is extensively used in studies investigating growth hormone dynamics, pituitary function, and endocrine regulation . The complementary mechanisms of these peptides provide researchers with a sophisticated tool for exploring:

Pulsatile GH Release: The No DAC version of CJC-1295 enables studies of pulsatile GH secretion patterns, which are critical for understanding physiological hormone rhythms .
Receptor Synergy: The blend enables investigation of how GHRH and GHSR pathways interact at the cellular level, potentially revealing insights into receptor crosstalk and signal integration .
Hypothalamic-Pituitary Axis: Both peptides influence the hypothalamic-pituitary axis, making them valuable for studying feedback mechanisms and hormonal regulation .

Muscle Growth and Recovery Research

The blend is widely studied for its effects on muscle tissue and recovery processes:

Muscle Protein Synthesis: By increasing GH and IGF-1 levels, the blend promotes muscle protein synthesis, supporting muscle growth and retention .
Enhanced Recovery: The combination supports faster recovery after physical stress, injury, or intense training protocols .
Strength Research: Studies suggest the blend may support improvements in muscle strength and physical performance .

Metabolic Research and Body Composition

Growth hormone plays a crucial role in fat metabolism and body composition regulation :

Lipolysis Enhancement: By increasing GH levels, the blend promotes the breakdown of stored fats for energy utilization .
Fat Loss Research: The combination supports fat loss and body recomposition, particularly when studied alongside diet and exercise protocols .
Insulin Sensitivity: Research suggests the blend may improve insulin sensitivity, helping to reduce high blood sugars and support metabolic health .

Sleep Quality and Recovery Research

Ipamorelin’s selective GH stimulation supports natural sleep architecture and recovery :

Deep Sleep Enhancement: The blend has been shown to improve sleep by enhancing natural GH production, which is linked to deeper, more restorative sleep cycles .
Recovery Optimization: Better sleep quality aids physical recovery, mental clarity, and overall well-being .

Bone Density and Connective Tissue Research

Growth hormone and IGF-1 play essential roles in bone health and connective tissue integrity :

Bone Density Support: Increased GH and IGF-1 levels promote osteoblast activity and collagen synthesis, supporting skeletal health and fracture resistance .
Connective Tissue Repair: The blend supports healing of tendons, ligaments, and other connective tissues .

Skin and Hair Health Research

The rejuvenating effects of growth hormone on cells contribute to skin and hair health :

Collagen Production: Increased GH levels support collagen synthesis, improving skin elasticity and reducing signs of aging .
Hair Growth: The combination may support enhanced hair growth and improved hair quality .

Anti-Aging and Longevity Research

By supporting overall hormone balance and cellular health, the blend contributes to anti-aging research :

Cellular Repair: The peptides promote cellular repair and regeneration, helping to mitigate the effects of aging .
Energy and Vitality: Studies suggest the blend may help maintain youthful energy levels and cognitive function .

Immune Function Research

Growth hormone plays a role in immune system regulation :

Immune Support: The blend may strengthen immune function through its effects on GH and IGF-1 levels .
Inflammatory Response: Research suggests potential benefits for modulating inflammatory responses .

Quality Assurance: Setting the Standard for Research Compounds

Manufacturing Excellence

eupeptidelap.co.uk sources the CJC-1295 (No DAC) + Ipamorelin Blend from certified GMP facilities with rigorous quality control protocols :

HPLC Purity Analysis: ≥99% purity verified by high-performance liquid chromatography for each component
Mass Spectrometry Verification: Molecular weight confirmation via LC-HRMS
Batch-Specific Certificates of Analysis: Complete documentation for each production run
Precisely Blended: Each vial contains accurately measured quantities of both peptides for consistent research results

Chemical and Product Specifications

Specification	Detail
Product Name	CJC-1295 (No DAC) + Ipamorelin Blend
Blend Composition	CJC-1295 (No DAC) + Ipamorelin (precisely blended)
Total Peptide Mass	10 mg per vial
Purity	≥99% (HPLC verified)
Appearance	White to off-white lyophilized powder
Form	Lyophilized powder
Solubility	Soluble in sterile water, PBS, or neutral aqueous buffers
CJC-1295 CAS Number	863288-34-0
CJC-1295 Molecular Weight	~3367.9 Da
Ipamorelin CAS Number	170851-70-4
Ipamorelin Molecular Weight	711.9 Da
Storage (Lyophilized)	-20°C; protect from light and moisture
Storage (Reconstituted)	2-8°C; use within 4 weeks; do not freeze
Shipping	Ambient temperature with protective packaging
Intended Use	Research and laboratory use only
Documentation	Certificate of Analysis provided with each batch

Stability and Handling Guidelines

Lyophilized Powder Storage: Store the lyophilized blend at -20°C in a dry, dark environment, protected from light and moisture . Under proper storage conditions, the powder maintains stability for up to 24 months from the date of manufacture . Use manual-defrost freezers and store vials in the back (not doors) to avoid temperature fluctuations.

Reconstitution Protocol :

Allow vial and solvent to reach ambient temperature before opening to prevent condensation
Reconstitute using sterile water, bacteriostatic water, or appropriate buffer according to research protocol
Inject solvent slowly down the inside wall of the vial to minimize foaming
Gently swirl or roll the vial until fully dissolved—do not shake vigorously
If needed, a minimal 0.1% acetic acid pre-wet can aid dissolution before final dilution
Label the vial with the date of reconstitution
Refrigerate immediately at 2-8°C

Reconstituted Solution Storage: Store the reconstituted solution at 2-8°C and protect it from light. Use within 4 weeks (28 days) for optimal potency and safety. Do not freeze reconstituted solution .

Protection from Light and Moisture:

Store in original packaging protected from light
Keep vials tightly sealed when not in use
Allow refrigerated vials to reach room temperature before opening to prevent condensation

Key Benefits

Premium Quality Manufacturing: GMP-certified production, ≥99% HPLC-verified purity for each component
Synergistic Blend: Combines GHRH analog (CJC-1295) with selective GHSR agonist (Ipamorelin) for complementary pathway activation
Physiological Pulsatility: No DAC formulation supports natural pulsatile GH release patterns
Ipamorelin Selectivity: No significant effects on ACTH, cortisol, or prolactin—unique among GHRP-class peptides
Growth Hormone Signaling Research: Study pulsatile GH release and receptor-mediated endocrine signaling
Muscle Growth Research: Supports muscle protein synthesis and lean muscle mass studies
Recovery Studies: Accelerates tissue repair and recovery after physical stress or injury
Metabolic Research Applications: Investigate lipolysis, fat metabolism, and body composition
Sleep Quality Research: Enhances deep sleep architecture through natural GH stimulation
Bone Density Studies: Supports osteoblast activity and collagen synthesis
Anti-Aging Research: Promotes cellular repair and rejuvenation
Skin Health Research: Supports collagen production and skin elasticity
Well-Characterized Peptides: Extensive preclinical literature supports research applications
Clean Formulation: Precisely blended single vial for research consistency
Comprehensive Documentation: Certificates of Analysis with batch-specific purity data
48-Hour EU & UK Delivery: Rapid shipping to research facilities across Europe
Batch Consistency: Rigorous quality control ensures lot-to-lot reproducibility
EU Sourced: Available from within the European Union

Frequently Asked Questions

Q: What is the CJC-1295 (No DAC) + Ipamorelin blend?

A: This blend combines two complementary peptides: CJC-1295 (No DAC), a synthetic analog of growth hormone-releasing hormone (GHRH), and Ipamorelin, a highly selective growth hormone secretagogue . Together, they work synergistically to stimulate natural growth hormone release through complementary pathways .

Q: What does “No DAC” mean?

A: “No DAC” stands for “No Drug Affinity Complex.” This version of CJC-1295 does not contain the acetate that binds to albumin to extend half-life, resulting in a shorter duration of action that mimics the body’s natural pulsatile GH release rather than a constant elevation . This is often preferred for research aimed at preserving physiological hormone rhythms.

Q: What purity level can I expect when I buy this blend from eupeptidelap.co.uk?

A: All CJC-1295 (No DAC) + Ipamorelin Blend from eupeptidelap.co.uk is tested to ≥99% purity by HPLC for each component . Each batch is individually analyzed, and Certificates of Analysis are provided with every order, ensuring you receive material suitable for rigorous research applications.

Q: How should I store this peptide blend for long-term stability?

A: Store the lyophilized blend at -20°C in a dry, dark environment, protected from light and moisture . Under proper storage conditions, the powder maintains stability for up to 24 months . After reconstitution, store at 2-8°C and use within 4 weeks. Do not freeze reconstituted solution .

Q: What is the recommended reconstitution protocol for this blend?

A: Reconstitute using sterile water, bacteriostatic water, or appropriate buffer according to your research protocol . Inject the solvent slowly down the inside wall of the vial to minimize foaming, then gently swirl or roll the vial until fully dissolved. Do not shake vigorously. If needed, a minimal 0.1% acetic acid pre-wet can aid dissolution before final dilution .

Q: What research areas commonly use this peptide blend?

A: This blend is widely used in growth hormone signaling research, muscle growth and recovery studies, metabolic research (fat loss, body composition), sleep quality research, bone density studies, anti-aging research, skin health research, and endocrine regulation studies .

Q: Is Ipamorelin different from other growth hormone secretagogues?

A: Yes. Ipamorelin is unique among GHRP-class peptides for its high selectivity. It stimulates GH release without significantly affecting adrenocorticotropic hormone, prolactin, follicle-stimulating hormone, luteinizing hormone, thyroid-stimulating hormone, or cortisol levels . This selectivity makes it particularly valuable for isolating GH-specific effects in research.

Q: Do you ship this peptide blend to EU countries?

A: Yes. As a dedicated EU peptide supplier, we ship the CJC-1295 (No DAC) + Ipamorelin Blend to all European Union member states with our guaranteed 48 hour delivery peptide service. Our EU fulfilment centre ensures rapid delivery without customs delays. All shipments use protective packaging to maintain compound integrity during transit .

Q: What documentation do you provide with this blend orders?

A: Every order includes a Certificate of Analysis (COA) with batch-specific purity data. Additional documentation, including HPLC chromatograms and mass spectrometry data, is available upon request for researchers requiring comprehensive analytical verification .

Q: How long does it take to see effects in research models?

A: Research protocols typically observe initial effects such as improved sleep quality and recovery within 1-2 weeks. Body composition changes typically become noticeable at 4-6 weeks, with progressive improvements continuing through 3-6 months of consistent administration .

Q: What is the half-life of CJC-1295 No DAC?

A: The No DAC version has a significantly shorter half-life than the DAC version, which has a half-life of 5-8 days . The No DAC formulation is designed to mimic natural pulsatile GH release rather than providing continuous elevation .

Q: Do you offer bulk quantities of this peptide blend for institutional research?

A: Yes. We accommodate bulk orders for research institutions. Contact our team at sales@eupeptidelap.co.uk for volume pricing, custom requirements, and supply agreements for ongoing research programs. ...........................................

Advance Your Research with CJC-1295 + Ipamorelin Blend

eupeptidelap.co.uk is your trusted source for the CJC-1295 (No DAC) + Ipamorelin 10mg Blend, the premium choice for researchers investigating growth hormone dynamics, tissue regeneration, metabolic function, and recovery mechanisms. With well-characterized mechanisms, complementary receptor targeting, and extensive peer-reviewed literature supporting its research applications , this blend represents a sophisticated tool for exploring the complex biology of the GH axis. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Whether you are exploring muscle recovery pathways, designing metabolic studies, investigating sleep architecture, or researching anti-aging mechanisms, our rigorously tested blend provides the quality and consistency your work demands.

Order today and experience the eupeptidelap.co.uk difference – premium quality, rapid 48-hour delivery across the EU and UK, and expert support for the European research community.

........ .. .. google

Muscle loss model

CJC-1295 (no DAC), Ipamorelin 10mg (Blend)